Cargando…

Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial

AIMS: The randomized, controlled EAST-AFNET 4 trial showed that early rhythm control (ERC) reduces the rate of a composite primary outcome (cardiovascular death, stroke, or hospitalization for worsening heart failure or acute coronary syndrome) by ∼20%. The current study examined the cost-effectiven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gottschalk, Sophie, Kany, Shinwan, König, Hans-Helmut, Crijns, Harry JGM, Vardas, Panos, Camm, A John, Wegscheider, Karl, Metzner, Andreas, Rillig, Andreas, Kirchhof, Paulus, Dams, Judith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227663/ https://www.ncbi.nlm.nih.gov/pubmed/36966734 http://dx.doi.org/10.1093/europace/euad051

Ejemplares similares

Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial( )
por: Eckardt, Lars, et al.
Publicado: (2022)

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial
por: Metzner, Andreas, et al.
Publicado: (2021)

Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial
por: Metzner, Andreas, et al.
Publicado: (2021)

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
por: Willems, Stephan, et al.
Publicado: (2021)

Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial
por: Kany, Shinwan, et al.
Publicado: (2023)

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?
por: Kany, Shinwan, et al.
Publicado: (2021)

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
por: Rillig, Andreas, et al.
Publicado: (2021)

Generalizability of the EAST‐AFNET 4 Trial: Assessing Outcomes of Early Rhythm‐Control Therapy in Patients With Atrial Fibrillation
por: Dickow, Jannis, et al.
Publicado: (2022)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
por: Schnabel, Renate B, et al.
Publicado: (2022)

Update Vorhofflimmern: Die ESC-Leitlinien 2020 sowie aktuelle Daten zur frühen antiarrhythmischen Therapie
por: Schleberger, Ruben, et al.
Publicado: (2021)

Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry
por: Haeusler, Karl Georg, et al.
Publicado: (2015)

Ablation of Outflow Tract Arrhythmias in Patients With and Without Structural Heart Disease—A Comparative Analysis
por: Schleberger, Ruben, et al.
Publicado: (2022)

Correction to: Management of pericardial tamponade in the electrophysiology laboratory: results from a national survey
por: Metzner, Andreas, et al.
Publicado: (2022)

Impact of atrial fibrillation pattern on outcomes after left atrial appendage closure: lessons from the prospective LAARGE registry
por: Kany, Shinwan, et al.
Publicado: (2021)

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
por: Reinecke, Holger, et al.
Publicado: (2018)

Pulsed-field ablation-based pulmonary vein isolation: acute safety, efficacy and short-term follow-up in a multi-center real world scenario
por: Lemoine, Marc D., et al.
Publicado: (2022)

Cryoballoon ablation guided by a novel wide-band dielectric imaging system
por: Rottner, Laura, et al.
Publicado: (2022)

Atrial high-rate episodes and stroke prevention
por: Camm, A. John, et al.
Publicado: (2017)

Safety and patient-reported outcomes in index ablation versus repeat ablation in atrial fibrillation: insights from the German Ablation Registry
por: Kany, Shinwan, et al.
Publicado: (2020)

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study
por: Reinecke, Holger, et al.
Publicado: (2022)

Temperature-controlled ablation of the mitral isthmus line using the novel DiamondTemp ablation system
por: Rottner, Laura, et al.
Publicado: (2022)

Influence of severe anemia on procedural safety and one-year outcome after left atrial appendage closure: Insights from a very high-risk cohort
por: Kany, Shinwan, et al.
Publicado: (2022)

AFNet Algorithm for Automatic Amniotic Fluid Segmentation from Fetal MRI
por: Costanzo, Alejo, et al.
Publicado: (2023)

Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation
por: Kany, Shinwan, et al.
Publicado: (2021)

European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers
por: Kotecha, Dipak, et al.
Publicado: (2018)

Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC – AFNET 9
por: Fabritz, Larissa, et al.
Publicado: (2022)

Recent advances in rhythm control for atrial fibrillation
por: Bond, Richard, et al.
Publicado: (2017)

A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction
por: Rottner, Laura, et al.
Publicado: (2023)

Innate Immunity and Alcohol
por: Kany, Shinwan, et al.
Publicado: (2019)

Reduction in left atrial and pulmonary vein dimensions after ablation therapy is mediated by scar
por: Rottner, Laura, et al.
Publicado: (2021)

The RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapy
por: Pavlovic, Davor, et al.
Publicado: (2018)

PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
por: Syeda, Fahima, et al.
Publicado: (2017)

Cytokines in Inflammatory Disease
por: Kany, Shinwan, et al.
Publicado: (2019)

Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines
por: Kirchhof, Paulus
Publicado: (2017)

Remote Cardiac Rhythm Monitoring in the Era of Smart Wearables: Present Assets and Future Perspectives
por: Xintarakou, Anastasia, et al.
Publicado: (2022)

Psychometric Properties of the EQ-5D for the Assessment of Health-Related Quality of Life in the Population of Middle-Old and Oldest-Old Persons: Study Protocol for a Systematic Review
por: Gottschalk, Sophie, et al.
Publicado: (2020)

Measurement properties of the EQ-5D in populations with a mean age of ≥ 75 years: a systematic review
por: Gottschalk, Sophie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pv1c23hoqjn7utdhp4d84bfb0m